Medicines, 2019
Shortlist up to four to read them side by side.
2,152 medicine recalls FDA’s Enforcement Report published in 2019, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 5, 2026.
2,152of 2,152 medicine recallsshown with your filters
The list
- Medicine recall WAL-DRAM 2 (meclizine Hydrochloride) 25 mg tablets Subpotent Drug Class IIIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedNov 20, 2019ClassClass IIIStatusTerminatedWhereNationwide, and Guam and Northern Mariana Islands named
- Medicine recall Motion Sickness Strips (meclizine hydrochloride) 25 mg strips, 8-count box Subpotent Drug Class IIIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 2 states named PublishedNov 20, 2019ClassClass IIIStatusTerminatedWhereNationwide, and Guam and Northern Mariana Islands named
- Medicine recall Viatrexx-Connectissue, 10 mL Sterile multi-dose vial Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Viatrexx-MuSkel-Neural, 10 mL Sterile multi-dose vial Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Viatrexx-Ouch, 10 mL Sterile multi-dose vial Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Viatrexx-Ithurts, 10 mL Sterile multi-dose vial Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Viatrexx-Adipose, 10 mL Sterile multi-dose vial Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Viatrexx-Systemic Detox, 10 mL Sterile multi-dose vial Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Viatrexx-Articula, 10 mL Sterile multi-dose vial Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Viatrexx-Neuro 3, 10 mL Sterile multi-dose vial Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Viatrexx-Infla, 10 mL Sterile multi-dose vial Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Viatrexx-Collagen, 10 mL Sterile multi-dose vial Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Viatrexx-Prolo, 10 mL Sterile multi-dose vial Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Viatrexx-Lymph 1, 10 mL Sterile multi-dose vial Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Viatrexx-Mesenchyme, 10 mL Sterile multi-dose vial Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Viatrexx-GI, 10 mL Sterile multi-dose vial Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Viatrexx-Arthros, 10 mL Sterile multi-dose vial Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Viatrexx-Immunexx, 10 mL Sterile multi-dose vial Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Viatrexx-Relief +, 10 mL Sterile multi-dose vial Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Viatrexx-Intra-Cell, 10 mL Sterile multi-dose vial Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Viatrexx-Facial, 10 mL Sterile multi-dose vial Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Viatrexx-Hair, 10 mL Sterile multi-dose vial Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Viatrexx-Neuro, 10 mL Sterile multi-dose vial Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Viatrexx-Male+, 10 mL Sterile multi-dose vial Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Viatrexx-ANS/CNS, 10 mL Sterile multi-dose vial Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility. Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Hydrocodone Bitartrate and Homatropine Methlybromide Oral Solution 5 mg/1.5 mg per 5 mL, 473 mL bottles Presence of Foreign Substance: Black particles were found in the lots during retain sample inspection Class IIFDA’s classNov 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Dr. Reddy’s: Ranitidine Capsules 150 mg, Rx a.) 60 count bottles (NDC 55111-129-60) b.) 500 count bottles… CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classNov 13, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 13, 2019ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Ranitidine Tablets, USP 150 mg, 190 count bottles CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classNov 13, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 13, 2019ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Ranitidine Tablets, USP 150 mg, a.) 24 count bottles (NDC 0363-0010-34), b.) 65 count bottles (NDC… CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classNov 13, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 13, 2019ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Ranitidine Tablets, USP 150 mg, a.) 65 count bottles (NDC 49035-404-61) b.) 130 count bottles (NDC… CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classNov 13, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 13, 2019ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Ranitidine Tablets, USP 150 mg, a.) 24 count bottles (NDC 30142-505-34), b.) 50 count bottles (NDC… CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classNov 13, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 13, 2019ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Ranitidine Tablets, USP 75 mg, a.) 30 count bottles (NDC 69842-871-30) b.) 80 count bottles (NDC… CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classNov 13, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 13, 2019ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Ranitidine Tablets, USP 75 mg 30 count bottles (NDC 30142-131-30) (Kroger) CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classNov 13, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 13, 2019ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Ranitidine Tablets 75 mg, a.) 30 count bottles (NDC 63868-482-30), 60 count bottles (NDC 63868-482-60) (CDMA)… CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classNov 13, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 13, 2019ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Ranitidine Tablets, USP 150 mg, a.) 95 count bottles (NDC 43598-808-62), b.) 220 count bottles (NDC… CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classNov 13, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 13, 2019ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Ranitidine Tablets, USP 150 mg, a.) 24 count bottles (NDC 71713-203-02), b.)95 count bottles (NDC… CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classNov 13, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 13, 2019ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Ranitidine Tablets, USP 75 mg CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classNov 13, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 13, 2019ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Ranitidine Tablets, USP 150 mg, 40 count bottles CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classNov 13, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 13, 2019ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Dr. Reddy’s Ranitidine Capsules, USP 300 mg, a.) 30 count bottles (NDC 55111-130-30) b.) 100 count bottles… CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classNov 13, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 13, 2019ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Dr. Reddy’s Ranitidine Tablets, USP 75 mg, 60 count bottles, NDC 55111-131-60, (OTC) CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classNov 13, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 13, 2019ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Dr. Reddy’s Ranitidine Tablets, USP 150 mg, 24 count bottles, NDC 55111-404-34 (OTC) CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classNov 13, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 13, 2019ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Ranitidine Tablets, USP 75 mg, a.) 30- count bottles (NDC 0363-0131-30), b.) 80-count bottles (NDC… CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classNov 13, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 13, 2019ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Ranitidine Tablets, USP 150 mg, a.) 24 count bottles (NDC 63868-480-24), b.) 50-count bottles (NDC… CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classNov 13, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 13, 2019ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Ranitidine Tablets, USP 150 mg CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classNov 13, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 13, 2019ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Alprazolam Tablets, USP 0.5 mg, 500-count bottles Presence of Foreign Substance Class IIFDA’s classNov 13, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedNov 13, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Basic Reset Earth Wash Cleaner and Personal Care, Eco Friendly, Non Toxic, 2 fl.oz Marketed without an Approved NDA/ANDA Class IIFDA’s classNov 13, 2019in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 13, 2019ClassClass IIStatusTerminatedWherePuerto Rico and US Virgin Islands
- Medicine recall Miracle Facelift Masque, All Natural, The Miracle in a Bottle, 2 fl Marketed without an Approved NDA/ANDA Class IIFDA’s classNov 13, 2019in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 13, 2019ClassClass IIStatusTerminatedWherePuerto Rico and US Virgin Islands
- Medicine recall Basic Reset Nuovi Skin Toner, Refined Ionyte, 4 FL Marketed without an Approved NDA/ANDA Class IIFDA’s classNov 13, 2019in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 13, 2019ClassClass IIStatusTerminatedWherePuerto Rico and US Virgin Islands
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
Source:
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.